TMCnet News

Marshall, Gerstein & Borun LLP Wins Three LMG Life Sciences Awards
[September 23, 2014]

Marshall, Gerstein & Borun LLP Wins Three LMG Life Sciences Awards


CHICAGO --(Business Wire)--

Intellectual Property law firm Marshall, Gerstein & Borun LLP is pleased to announce that the Firm was honored in three categories at the second annual LMG Life Sciences Awards, which recognize the very best life science practitioners and firms over the past 12 months from the United States, Canada and Europe. Awards garnered include:

Li-Hsien (Lily) Rin-Laures, M.D. was named Patent Prosecution Pharmaceutical Attorney of the Year an ...

Li-Hsien (Lily) Rin-Laures, M.D. was named Patent Prosecution Pharmaceutical Attorney of the Year and inducted into the LMG Life Sciences Hall of Fame. (Photo: Business Wire)

  • LMG Life Sciences Hall of Fame Inductee - Li-Hsien (Lily) Rin-Laures, M.D.
  • Patent Prosecution Pharmaceutical Attorney of the Year - Li-Hsien (Lily) Rin-Laures, M.D.
  • Hatch Waxman Impact Case of the Year - Pfizer Inc. and Northwestern University v. Teva Pharms., et al. - Case team members: Kevin M. Flowers, Ph.D., Mark H. Izraelewicz and Matthew C. Nielsen

Dr. Li-Hsien (Lily) Rin-Laures, M.D. is a leading partner in "one of the best biotechnology practices in the country," as ranked by Chambers USA. Dr. Rin-Laures, a former General Counsel of a publicly-held biotechnology company, regularly counsels clients - from Fortune 500 companies to startups - on patent strategy relating to new pharmaceutical/biotechnology product development, therapeutic uses, and product lifecycle management, as well as the interface with FDA regulations and related exclusivity provisions. Her unique insider's perspective, technical experience, and wide-ranging industry knowledge acquired from managing global patent portfolios for eight different approved drugs and numerous clinical trial candidates enables her to be a valuable strategic partner to clients.



Kevin M. Flowers, Ph.D., Mark H. Izraelewicz and Matthew C. Nielsen represented Northwestern University in a Hatch-Waxman suit against Teva Pharmaceuticals, in which seven generic drug companies sought to market generic versions of Lyrica®, a drug that has its origin in the research of a Northwestern University chemist. The Firm successfully represented Northwestern first in its claim that the patents covering the active ingredient in Lyrica® were valid, and again when the generic companies appealed the initial ruling.

The LMG Life Sciences award nominations are based on research and submissions undertaken by the editors of Euromoney's 2014 LMG Life Sciences guide, which is aimed at providing attorneys and law firms with information on the legal market and the U.S. life sciences industry. Research for the entire publication was based on reviewing nearly 1,000 interviews and surveys completed by partners active in the market. In the 2013 LMG Life Sciences guide, Marshall, Gerstein & Borun was "highly recommended" for patent prosecution and "highly recommended" for patent strategy and management.


About Marshall, Gerstein & Borun LLP

Marshall, Gerstein & Borun LLP, founded in 1955, is exclusively focused on intellectual property law, and protects, enforces, and transfers the intellectual property of its clients worldwide. The Firm delivers perspective and guidance where science, technology, and law converge. Nearly half of the Firm's professionals have been in-house as general counsel, patent counsel, technology transfer managers, scientists, engineers, or consultants. The Firm's professionals offer depth of talent and seasoned experience in devising and executing intellectual property strategy and comprehensive IP solutions. Learn more at www.marshallip.com.


[ Back To TMCnet.com's Homepage ]